Monogram Technologies Inc.

Equities

MGRM

US6097861081

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
2.04 USD +3.03% Intraday chart for Monogram Technologies Inc. +3.55% -40.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Monogram Orthopaedics Inc has Changed its Name to Monogram Technologies Inc CI
Monogram Orthopaedics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Monogram Orthopaedics Inc. Provides Regulatory Update Following Meeting with FDA CI
Top Premarket Decliners MT
Monogram Orthopaedics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Monogram Orthopaedics, Inc. Elects Colleen Gray to Its Board CI
Monogram Orthopaedics, Inc. Delivers First Surgical Robot CI
Certain Common Stock of Monogram Orthopaedics, Inc. are subject to a Lock-Up Agreement Ending on 14-NOV-2023. CI
Top Premarket Decliners MT
Monogram Orthopaedics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Monogram Orthopaedics Files Shelf for Up to 6.5 Million Common Shares MT
Monogram Orthopaedics Inc. Announces Completion of the Development Phase and the Start of the Verification Phase for its Next-Generation Autonomous Surgical Robotic System CI
Monogram Orthopaedics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Monogram Orthopaedics, Inc. announced that it expects to receive $19.999997 million in funding from B. Riley Principal Capital II, LLC CI
Monogram Orthopaedics Receives Conditional Purchase Order to Begin Pilot Program With Global Distributor MT
Monogram Orthopaedics Inc. Secures First Conditional Purchase Order to Initiate Pilot Program with Global Distributor CI
Monogram Orthopaedics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Monogram Orthopaedics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program CI
Monogram Orthopaedics, Inc.(NasdaqCM:MGRM) added to NASDAQ Composite Index CI
Monogram Orthopaedics, Inc. has completed an IPO in the amount of $17.216147 million. CI
Monogram Orthopaedics, Inc. Auditor Raises 'Going Concern' Doubt CI
Monogram Orthopaedics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Monogram Orthopaedics, Inc. has filed an IPO in the amount of $30 million. CI
Chart Monogram Technologies Inc.
More charts
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
More about the company